Chatterjee M, Banerjee M R
Cancer Lett. 1982 Sep;16(3):239-45. doi: 10.1016/0304-3835(82)90002-7.
Influence of estrogen and progesterone on the inhibitory action of N-(4-hydroxyphenyl) retinamide (4-HPR) was examined during the promotional stage of 7,12-dimethylbenz[alpha]anthracene (DMBA) transformation of the epithelial cells in culture of the whole mammary organs of BALB/c mice. In medium containing insulin, prolactin, hydrocortisone, and aldosterone, 4-HPR caused 68% inhibition of transformation as determined by the presence of nodule-like alveolar structures in the glands exposed to DMBA in vitro. Addition of estrogen and progesterone to the medium reduced this pronounced inhibitory action of 4-HPR to only 15%. While the medium containing insulin, prolactin, growth hormone, estrogen and progesterone was highly conducive to DMBA transformation, 4-HPR inhibition of transformation was limited to only 21%. The antagonistic action of the ovarian steroid hormones was present also at the level of frequency of nodule-like alveolar lesions (NLAL) per gland. Although both ovarian hormones reduced the inhibitory action of 4-HPR, on mammary cell transformation, the antagonistic action of estrogen was noticeably more pronounced.
在BALB/c小鼠全乳腺器官培养物中,研究了雌激素和孕酮对N-(4-羟基苯基)视黄酸(4-HPR)抑制7,12-二甲基苯并[a]蒽(DMBA)诱导上皮细胞转化促癌阶段作用的影响。在含有胰岛素、催乳素、氢化可的松和醛固酮的培养基中,通过体外暴露于DMBA的腺体中结节样肺泡结构的存在来确定,4-HPR可导致68%的转化抑制。向培养基中添加雌激素和孕酮后,4-HPR这种显著的抑制作用仅降至15%。虽然含有胰岛素、催乳素、生长激素、雌激素和孕酮的培养基非常有利于DMBA转化,但4-HPR对转化的抑制作用仅局限于21%。卵巢甾体激素的拮抗作用在每个腺体的结节样肺泡病变(NLAL)频率水平上也存在。虽然两种卵巢激素都降低了4-HPR对乳腺细胞转化的抑制作用,但雌激素的拮抗作用明显更显著。